Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

INTRODUCTION: New target-specific oral anticoagulants may have benefits, such as shorter hospital length of stay, compared to warfarin in patients with nonvalvular atrial fibrillation (NVAF). This study aimed to assess, among patients with NVAF, the effect of rivaroxaban versus warfarin on health ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Laliberté, François, Cloutier, Michel, Crivera, Concetta, Nelson, Winnie W., Olson, William H., Schein, Jeffrey, Vanderpoel, Julie, Germain, Guillaume, Lefebvre, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376962/
https://www.ncbi.nlm.nih.gov/pubmed/25784509
http://dx.doi.org/10.1007/s12325-015-0189-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376962/
https://www.ncbi.nlm.nih.gov/pubmed/25784509
http://dx.doi.org/10.1007/s12325-015-0189-1

Ejemplares similares